Galapagos (0JXZ) Receives a Sell from Bank of America Securities
Bank of America Securities analyst Jason Gerberry has maintained a Sell rating on Galapagos (0JXZ), with shares closing at €26.84. The analyst consensus is a Moderate Sell, with an average price target of €23.50, indicating a potential downside of 12.44%. Kepler Capital also reiterated a Sell rating with the same price target. Gerberry, a 5-star analyst, has an average return of 10.6% and a 58.23% success rate, covering the Healthcare sector.
In a report released on November 7, Jason Gerberry from Bank of America Securities maintained a Sell rating on Galapagos. The company’s shares closed last Friday at €26.84.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, Gerberry is a 5-star analyst with an average return of 10.6% and a 58.23% success rate. Gerberry covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals, Jazz Pharmaceuticals, and United Therapeutics.
Currently, the analyst consensus on Galapagos is a Moderate Sell with an average price target of €23.50, representing a -12.44% downside. In a report released on November 6, Kepler Capital also maintained a Sell rating on the stock with a €23.50 price target.
